Develops drugs for skin diseases, including molluscum contagiosum and impetigo.
Jun 2026Revenue $43.3M/yrExpenses $101M/yr
No trendCash runway ≈ 7 months from Jun 2026
Figures by year
When will Pelthos Therapeutics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $43.3M and expenses $101M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $16.8M | $49.2M | −$32.4M |
| Dec 2024 | $0.00 | $7.57M | −$7.57M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.